File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.chest.2015.12.017
- Scopus: eid_2-s2.0-84973520024
- WOS: WOS:000377296000019
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Efficacy of EGFR tyrosine kinase inhibitors in the adjuvant treatment for operable Non-small cell lung cancer by a meta-analysis
Title | Efficacy of EGFR tyrosine kinase inhibitors in the adjuvant treatment for operable Non-small cell lung cancer by a meta-analysis |
---|---|
Authors | |
Keywords | adjuvant treatment epidermal growth factor receptor tyrosine kinase inhibitors non-small cell lung cancer operable survival |
Issue Date | 2016 |
Publisher | American College of Chest Physicians. The Journal's web site is located at http://www.chestjournal.org |
Citation | Chest, 2016, v. 149 n. 6, p. 1384-1392 How to Cite? |
Abstract | BACKGROUND: The role of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in the adjuvant treatment of non-small cell lung cancer (NSCLC) has not been well-established. Our meta-analysis aimed to determine whether the administration of EGFR-TKIs could improve the outcomes of patients with NSCLC undergoing complete resection. |
Persistent Identifier | http://hdl.handle.net/10722/235690 |
ISSN | 2023 Impact Factor: 9.5 2023 SCImago Journal Rankings: 2.123 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Huang, Q | - |
dc.contributor.author | LI, J | - |
dc.contributor.author | Sun, Y | - |
dc.contributor.author | Wang, R | - |
dc.contributor.author | Cheng, X | - |
dc.contributor.author | Chen, H | - |
dc.date.accessioned | 2016-10-14T13:54:50Z | - |
dc.date.available | 2016-10-14T13:54:50Z | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | Chest, 2016, v. 149 n. 6, p. 1384-1392 | - |
dc.identifier.issn | 0012-3692 | - |
dc.identifier.uri | http://hdl.handle.net/10722/235690 | - |
dc.description.abstract | BACKGROUND: The role of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in the adjuvant treatment of non-small cell lung cancer (NSCLC) has not been well-established. Our meta-analysis aimed to determine whether the administration of EGFR-TKIs could improve the outcomes of patients with NSCLC undergoing complete resection. | - |
dc.language | eng | - |
dc.publisher | American College of Chest Physicians. The Journal's web site is located at http://www.chestjournal.org | - |
dc.relation.ispartof | Chest | - |
dc.subject | adjuvant treatment | - |
dc.subject | epidermal growth factor receptor tyrosine kinase inhibitors | - |
dc.subject | non-small cell lung cancer | - |
dc.subject | operable | - |
dc.subject | survival | - |
dc.title | Efficacy of EGFR tyrosine kinase inhibitors in the adjuvant treatment for operable Non-small cell lung cancer by a meta-analysis | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.chest.2015.12.017 | - |
dc.identifier.scopus | eid_2-s2.0-84973520024 | - |
dc.identifier.hkuros | 268415 | - |
dc.identifier.volume | 149 | - |
dc.identifier.issue | 6 | - |
dc.identifier.spage | 1384 | - |
dc.identifier.epage | 1392 | - |
dc.identifier.isi | WOS:000377296000019 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 0012-3692 | - |